NCT07626281
- Conditions
- Inclisiran Formulation
- Locations
-
- Lenexa Research Unit Lenexa, Kansas, United States
- Cardiovasular Renal Metabolism San Antonio, Texas, United States
- Salt Lake City Research Unit Salt Lake City, Utah, United States